OR WAIT null SECS
© 2023 MJH Life Sciences and Consultant Live. All rights reserved.
December 30, 2022
Why has this season brought an unprecedented number of severe RSV infections, and why is vaccine development taking so long?
September 23, 2022
RBX2660 is a standardized, stabilized, investigational microbiota-based live biotherapeutic.
May 27, 2022
RBX2660, an investigational microbiota-based live biotherapeutic for the treatment of C difficile, safely and effectively reduced recurrent C diff for 6 months.
December 15, 2021
Stigma, and a lack of communication and awareness all inhibit HIV PrEP uptake, but digital health and new forms of PrEP could boost users.